IL6 and diabetic kidney disease: C5a can stimulate leukocyte infiltration into the damaged tissues and induce the release of pro-inflammatory factors, such as IL-1β, IL-6, and TNF-α, whereas the C5aR antagonist (C5aR) has the function of reducing DKD kidney tissue damage (Tan et al., 2022).